Ontology highlight
ABSTRACT:
SUBMITTER: Barbieri MA
PROVIDER: S-EPMC7230621 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
Barbieri Maria Antonietta MA Cicala Giuseppe G Cutroneo Paola Maria PM Gerratana Elisabetta E Palleria Caterina C De Sarro Caterina C Vero Ada A Iannone Luigi L Manti Antonia A Russo Emilio E De Sarro Giovambattista G Atzeni Fabiola F Spina Edoardo E
Journal of clinical medicine 20200424 4
Post-marketing surveillance activities are essential to detect the risk/benefit profile of biologic disease-modifying antirheumatic drugs (bDMARDs) in inflammatory arthritis. The aim of this study was to evaluate adverse events (AEs) in patients treated with bDMARDs in rheumatology during a prospective pharmacovigilance study from 2016 to 2018. Descriptive statistical analyses were performed to evaluate bDMARDs-related variables of patients without AEs/failures vs patients with AEs and failures. ...[more]